JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB325307

Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2

Be the first to review this product! Submit a review

|

(0 Publication)

Fully defined & ready-to-go fluorescent camelid single-domain antibody (sdAb) conjugates featuring FluoTag® and Smart Secondaries® technologies.

  • Quantitative and reliable readout in all fluorescence-based analyses
  • Defined number of fluorophores enhance brightness of signals
  • Improved localization accuracy ideal for super resolution imaging
  • Recognizes conventional immunoglobulins with exquisite species and isotype specificity
2 Images
Immunocytochemistry/ Immunofluorescence - Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2 (AB325307)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2 (AB325307)

Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized, PBS washing, and blocked with 10% normal goat serum in PBS HeLa (human cervical cancer cells) cells labelling Actin with ab213251 at 1 : 400 (1.20 µg/ml) dilution, followed by ab325307 Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2 at 1/500 (0.15 µg/ml per sdAb) dilution (red).

Confocal image showing cytoplasmic staining in HeLa cells (shown in red). Nuclear DNA was labelled with DAPI (shown in blue).

Image was taken with a fluorescence microscope (Zeiss Axio Imager Z1).

Secondary antibody only control : Secondary antibody is ab325307 Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2 at 1/500 (0.15 µg/ml per sdAb) dilution.

Other - Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2 (AB325307)
  • Other

Supplier Data

Other - Alpaca multiclonal [2F3 / 2E5] Anti-human IgG1/IgG4 antibody (AZdye 568) - FluoTag®-X2 (AB325307)

Smart Secondary®

Smart Secondary® sdAb generally recognize the Fc domain on the respective primary antibody (the only exception being the FluoTag-X2 anti-Mouse Kappa light chain). Due to the inherent symmetry of the target antibody, two secondary nanobodies will be able to bind each primary antibody. Our secondary FluoTag®-X2 reagents will therefore target 4 fluorophores to each primary antibody. Our anti-Rabbit IgG tools are also available as FluoTag®-X4.

This reagent is a blend of two sdAbs independently binding the same target molecule. As each target site is present twice and each sdAb carries two fluorophores, this reagent can target up to eight fluorophores to each primary antibody – ideal for bright images!

Key facts

Host species

Alpaca

Target species

Human

Target isotype

IgG1, IgG4

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

AZdye 568

Excitation/Emission

Ex: 578nm, Em: 602nm

Applications

ICC/IF

applications

Clonality

Multiclonal

Clone number

2F3 / 2E5

Isotype

IgG

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/500", "notes":"<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Size-exclusion chromatography
Storage buffer
Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1 month
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

Target data

Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com